Biosimilars Series: Strategic issues - Potential remains uncertain

Questions: Discounts, Updates etc.

Price: $3,800.00

Publication Date: 2007-10-03

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Significant barriers to entry into the biosimilars market exist. High up-front investment and the need for specific expertise favor big players. Understanding of the marketplace is critical for success acceptance by key stakeholders is crucial for market uptake of biosimilars and achieving preferential reimbursement status through constant review of the pricing strategy is desirable.


Scope

  • In-depth analysis of factors influencing market uptake of biosimilars
  • Analysis of the pricing and reimbursement environment for biosimilars
  • Detailed analysis of barriers to entry and strategies for success in the biosimilar market
  • Overview of strategies for originators' market share protection


    • Report Highlights
    Lack of automatic substitution with biosimilars means that intense promotion strategies need to be employed. Market uptake of biosimilars is highly dependent on acceptance by all key stakeholders especially physicians. All stakeholders need to be informed about biosimilars and various channels can be used.

    Payers' reaction to biosimilars is not known, but it is expected they will embrace them after a lag period. Standard incentives used to encourage generics use may not be applicable to biosimilars distributed in hospitals and alternative approaches need to be used.

    Barriers to entry remain high: high development and marketing costs compounded with the need for specialist expertise favor big players with strong financial backing and experience in branded generics industry. However smaller specialist players are well positioned to enter this market through co-development and co-marketing agreements.


    Reasons to Purchase

  • Identify key stakeholders than need to be targeted in order to achieve high uptake of biosimilars
  • Understand the pricing and reimbursement environment of biosimilars, barriers to entry and key strategies for success in the biosimilars market
  • Gain insight into strategies employed by innovative pharmaceutical and biotechnology companies in order to maintain their market share

    • Table of Contents

    Other users found this report page using the following search terms: Biosimilar generic biogeneric biosimilars biosimilar market omnitrope share manufacturing development small marketing issues

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.